Maridebart cafraglutide showed significant weight loss in adults with obesity, with or without type 2 diabetes, in a phase 2 trial. The drug combines GLP-1 receptor agonism with GIP receptor ...
Lin Tian receives funding from the Advanced Strategic Capabilities Accelerator (ASCA) and the Defence Innovation Network. Marian-Andrei Rizoiu receives funding from the Advanced Strategic Capabilities ...
Oil posted a fourth monthly loss as traders looked ahead to an OPEC+ meeting this weekend and assessed how the potential of easing geopolitical tensions from Kyiv to Caracas may impact an oversupplied ...
A cooling-system failure at CyrusOne forced CME Group to halt trading across commodities, equities, bonds, and FX. WTI and Brent were already on track for a fourth monthly decline due to oversupply ...
Several major automotive brands are offering Black Friday incentives. Brands like Toyota and Mazda have car and SUV lease deals for under $200 a month. Black Friday isn't just for large TVs and air ...
On Monday, Anthropic announced Opus 4.5, the latest version of its flagship model. It’s the last of Anthropic’s 4.5 series of models to be released, following the launch of Sonnet 4.5 in September and ...
Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for weight management. Lilly said in an announcement that the model is built on ...
Imagine investing in a promising project, only to realize years later that it’s taking far longer than expected to recoup your initial outlay. Wouldn’t it have been invaluable to know upfront how long ...
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy® End-to-end GLP-1 care done right: ...
Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...
PITTSBURGH — The Cincinnati Bengals’ plan to have Joe Flacco keep them competitive until Joe Burrow can return from toe surgery has hit a major snag. Flacco was riding high after his first game ...